Price (delayed)
$194.12
Market cap
$9.94B
P/E Ratio
19.89
Dividend/share
N/A
EPS
$9.76
Enterprise value
$12.9B
Charles River Laboratories, Inc., is an American corporation specializing in a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted
There are no recent dividends present for CRL.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.